Page last updated: 2024-09-03

3-methyl-3,4-epoxybutyl diphosphate and pamidronate

3-methyl-3,4-epoxybutyl diphosphate has been researched along with pamidronate in 1 studies

Compound Research Comparison

Studies
(3-methyl-3,4-epoxybutyl diphosphate)
Trials
(3-methyl-3,4-epoxybutyl diphosphate)
Recent Studies (post-2010)
(3-methyl-3,4-epoxybutyl diphosphate)
Studies
(pamidronate)
Trials
(pamidronate)
Recent Studies (post-2010) (pamidronate)
5002,220368444

Protein Interaction Comparison

ProteinTaxonomy3-methyl-3,4-epoxybutyl diphosphate (IC50)pamidronate (IC50)
Farnesyl pyrophosphate synthaseHomo sapiens (human)1.0745

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Casetti, R; Colizzi, V; D'Offizi, G; Dieli, F; Malkovsky, M; Mattei, M; Perretta, G; Poccia, F; Taglioni, A1

Other Studies

1 other study(ies) available for 3-methyl-3,4-epoxybutyl diphosphate and pamidronate

ArticleYear
Drug-induced expansion and differentiation of V gamma 9V delta 2 T cells in vivo: the role of exogenous IL-2.
    Journal of immunology (Baltimore, Md. : 1950), 2005, Aug-01, Volume: 175, Issue:3

    Topics: 2,3-Diphosphoglycerate; Animals; Antigens; CD4-CD8 Ratio; Cell Differentiation; Cell Proliferation; Cells, Cultured; Diphosphates; Diphosphonates; Epoxy Compounds; Hemiterpenes; Immunologic Memory; Injections, Intravenous; Injections, Subcutaneous; Interferon-gamma; Interleukin-2; Macaca fascicularis; Organophosphorus Compounds; Pamidronate; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocyte Subsets; Th1 Cells

2005